Biologic IgG level in primary immunodeficiency disease: The IgG level that protects against recurrent infection - 15/08/11
Doi : 10.1016/j.jaci.2008.04.044
Vincent R. Bonagura, MD a, b 
, Robert Marchlewski, MD a, Amanda Cox, MD a, David W. Rosenthal, DO a, b
, Robert Marchlewski, MD a, Amanda Cox, MD a, David W. Rosenthal, DO a, b a Division of Allergy/Immunology, Department of Pediatrics, Schneider Children’s Hospital, North Shore-LIJ Health System, Great Neck, NY
b Elmezzi Graduate School of Molecular Medicine, Feinstein Institute for Medical Research, North Shore-LIJ Health System, Manhasset, NY
El texto completo de este artículo está disponible en PDF.
| Disclosure of potential conflict of interest: V. R. Bonagura has received support from the National Institutes of Health and has served as a member for CST. The rest of the authors have declared that they have no conflict of interest. |
© 2008
American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 122 - N° 1
P. 210-212 - juillet 2008 Regresar al número
Artículo precedente
- Allergy rescue medication in schools: Modeling a new approach
- Laura Norton, Audrey Dunn Galvin, Jonathan O’Brien Hourihane
- Modifications improve an offline exhaled nitric oxide collection device for use with young children
- Matthew S. Perzanowski, Maria Jose Rosa, Adnan Divjan, Alina Johnson, Judith S. Jacobson, Rachel L. Miller
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?